Related Experiment Videos
Geneva experience with the Ineraid multichannel cochlear implant
P Montandon1, M Pelizzone, A Kasper
1Department of Otolaryngology, Cantonal University Hospital, Geneva, Switzerland.
Summary
The Ineraid multichannel intracochlear implant offers significant speech recognition for deaf patients. This study critically assessed its value in diverse patient groups, including those with congenital deafness and ossified cochleas.
Area of Science:
- Otorhinolaryngology
- Biomedical Engineering
- Neuroscience
Background:
- The Ineraid is a recent multichannel intracochlear implant.
- It has the potential to restore high levels of speech recognition in totally deaf individuals.
Purpose of the Study:
- To critically assess the clinical value of the Ineraid implant.
- To evaluate its efficacy in a diverse patient population, including those with congenital deafness, ossified cochleas, and perilingual children.
Main Methods:
- Selection of the Ineraid device in 1985 due to clinical and research interests.
- Critical assessment of the implant's value without commercial ties.
- Evaluation across a range of patient cases.
Main Results:
- The Ineraid implant provides high levels of speech recognition.
- The device is effective in patients with challenging audiological conditions.
Conclusions:
- The Ineraid multichannel intracochlear implant is a valuable tool for restoring hearing.
- Its effectiveness is demonstrated across a spectrum of deafness etiologies and cochlear conditions.